Artal Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,000
| Closed | -$4.77M | – | 153 |
|
|
2021
Q2 | $4.77M | Hold |
10,000
| – | – | 0.1% | 115 |
|
|
2021
Q1 | $4.12M | Hold |
10,000
| – | – | 0.07% | 113 |
|
|
2020
Q4 | $4.9M | Sell |
10,000
-5,000
| -33% | -$2.45M | 0.11% | 102 |
|
|
2020
Q3 | $8.49M | Buy |
+15,000
| New | +$8.49M | 0.21% | 69 |
|
|
2018
Q1 | – | Sell |
-15,000
| Closed | -$3.04M | – | 106 |
|
|
2017
Q4 | $3.04M | Sell |
15,000
-12,500
| -45% | -$2.54M | 0.05% | 51 |
|
|
2017
Q3 | $8.82M | Sell |
27,500
-2,500
| -8% | -$802K | 0.15% | 27 |
|
|
2017
Q2 | $6.78M | Hold |
30,000
| – | – | 0.12% | 32 |
|
|
2017
Q1 | $6.76M | Sell |
30,000
-5,000
| -14% | -$1.13M | 0.15% | 31 |
|
|
2016
Q4 | $6.93M | Buy |
35,000
+10,000
| +40% | +$1.98M | 0.15% | 25 |
|
|
2016
Q3 | $6.15M | Buy |
25,000
+9,500
| +61% | +$2.34M | 0.12% | 28 |
|
|
2016
Q2 | $9.01M | Buy |
15,500
+4,250
| +38% | +$2.47M | 0.19% | 22 |
|
|
2016
Q1 | $5.98M | Buy |
11,250
+2,500
| +29% | +$1.33M | 0.12% | 26 |
|
|
2015
Q4 | $6.14M | Sell |
8,750
-1,250
| -13% | -$877K | 0.12% | 31 |
|
|
2015
Q3 | $5.93M | Buy |
10,000
+1,997
| +25% | +$1.18M | 0.13% | 22 |
|
|
2015
Q2 | $6.64M | Buy |
+8,003
| New | +$6.64M | 0.29% | 28 |
|